The virtual renal cancer MDT meeting

Date and time Thu 11 Feb 2021 from 6:00pm to 7:30pm
Location Online
Organised by Urology

In the past decade, there have been significant advances in the management of renal cancer with better ablation technologies, robotic nephron-sparing surgery, and a plethora of chemotherapy agents. Using carefully chosen cases and an MDT (multidisciplinary team) format, this webinar will update you on the latest evidence.

This webinar will review all relevant information from an MDT perspective about real cases. The cases have been selected to highlight some of the topical and controversial issues.

Topics to be covered:

Current indications for and limitations of ablation therapy in small renal masses.
The pros and cons of robotic partial nephrectomy versus ablation.
The latest evidence for surveillance of small renal masses in the elderly.
Whether there is a role for adjuvant chemotherapy in high-risk renal cancer.
Current indications for cytoreductive nephrectomy.

Join in the conversation online using #RSMUrology
Follow us on Twitter: @RoySocMed and @RSMUrology

Professor Noel Clarke

Consultant Urological Surgeon Professor of Urological Oncology The Christie and Salford Royal Hospitals Manchester

Speaker's biography

Professor Noel W Clarke MBBS ChM FRCS(Urol) specialises in secondary and tertiary referral complex pelvic and retroperitoneal surgery, research into Genito-Urinary malignancy and the delivery of cancer treatment in health care systems. He is closely involved with multiple large-scale GU cancer trials including the STAMPEDE, Radicals, Patch and Propel trials. He directs the Manchester University GU Ca Research Group and jointly leads the UK’s Manchester/Belfast FASTMAN Centre of Excellence for prostate cancer research.

He is joint clinical lead for the National Prostate Cancer Audit in England and Wales. Professor Clarke’s research interests encompass basic/translational science and trials in urological cancer. He has authored >250 peer-reviewed papers and 9 book chapters on urology and urological cancer.

Dr Miles Walkden

Consultant Interventional Radiologist, Renal ablation service Lead, University College Hospital and the Royal
Free Hospitals, London

Speaker's biography

Dr Walkden qualified from Guy’s and St Thomas’ London in 1997, initially training as a surgeon and gaining membership of the Royal College of Surgeons Edinburgh in
2002. He then went on to train in Radiology at St Georges Hospital and became a fellow of the Royal College of Radiologists in 2007.

Dr Walkden now specialises in urological interventional procedures including renal
ablation having performed over 350 cases, treatment of non-ischaemic priapism and
prostate artery embolization.

Mr Neil Barber

Consultant Urological Surgeon, Frimley Park Hospital

Professor Tom Powles

Consultant Oncologist, Barts Health

Professor David Nicol

Consultant Urological Surgeon, Royal Marsden 

Henry Tam

Consultant Radiologist, Imperial College Healthcare

Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.

Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.

Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.

All webinars will be available for registered delegates 30 days after on Zoom. The link will be sent 24 hours after the webinar takes place.

This webinar will be recorded and stored by the Royal Society of Medicine and may be  distributed  in future on various internet channels.